Drug intelligence / Profile preview

Blackpoint Oral Spray

Development stage
Preclinical
Lead developer
Blackpoint Biotech
Modality
Small Molecules
Administration
Sublingual, Oral
01

Overview

Blackpoint Oral Spray is a metered-dose delivery device (MDD) designed for the sublingual administration of pharmaceutical-grade tetrahydrocannabinol (THC). Developed by Blackpoint Biotech, the device delivers a precise 5mg dose of THC per spray in a fine aerosolized mist, facilitating rapid absorption through the oral mucosa and bypassing first-pass metabolism in the digestive system. The formulation contains 100 doses (500mg total THC) and is naturally flavored with plant-based terpenes such as limonene. It is manufactured according to EU GMP standards to provide medical cannabis patients with a reliable, repeatable, and discreet delivery method for controlled cannabinoid dosing without the need for inhalation of smoke.

Brand names
Blackpoint Oral Spray
Other names
Sublingual Oral SprayBlackpoint Oral Spray - THC 5mg per doseMetered Dose Device
02

Targets

CNR1 (Cannabinoid receptor 1)

Beyond the preview

Go deeper on Blackpoint Oral Spray.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Blackpoint Oral Spray.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call